Joseph K Belanoff Corcept Therapeutics Inc (CORT) insider trading activity

Joseph K Belanoff is Chief Executive Officer of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 539,228 shares of CORT, which is worth approximately $31.6 Million. The most recent transaction as insider was on Jul 31, 2024, when has been sold 259,583 shares (Common Stock) at a price of $38.67 per share, resulting in proceeds of $10,038,074. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 539K

0% 3M change

54.59% 12M change

Total Value Held $31.6 Million

JOSEPH K BELANOFF Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 31 2024	SELL Payment of exercise price or tax liability	$10,038,074 $38.67 p/Share	259,583 Reduced 32.5%	539,228 Common Stock
Jul 31 2024	BUY Exercise of conversion of derivative security	$1,480,500 $3.29 p/Share	450,000 Added 36.03%	798,811 Common Stock
Jul 06 2022	SELL Payment of exercise price or tax liability	$11,825,663 $26.21 p/Share	451,189 Reduced 56.4%	348,811 Common Stock
Jul 06 2022	BUY Exercise of conversion of derivative security	$1,664,000 $2.08 p/Share	800,000 Added 50.0%	800,000 Common Stock
Jan 22 2021	SELL Payment of exercise price or tax liability	$13,499,329 $28.06 p/Share	481,088 Reduced 14.58%	2,818,126 Common Stock
Jan 22 2021	BUY Exercise of conversion of derivative security	$3,536,000 $4.42 p/Share	800,000 Added 19.52%	3,299,214 Common Stock

JKB

Joseph K Belanoff

Chief Executive Officer

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account